200 related articles for article (PubMed ID: 9101994)
1. [With reference to later intra-/extrathoracic recurrence manifestations also after so-called radical operation: when are (neo-)adjuvant measures indicated?].
Drings P
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():805-9. PubMed ID: 9101994
[TBL] [Abstract][Full Text] [Related]
2. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
3. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
4. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
[TBL] [Abstract][Full Text] [Related]
5. [Bronchial cancer--adjuvant chemotherapy].
Drings P
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():89-94. PubMed ID: 1983675
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
Wolf M
Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
[TBL] [Abstract][Full Text] [Related]
7. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
8. [Which treatments should be proposed in resectable stage III cancers?].
Thibout Y; Cortot A; Chapet O; Mornex F; Milleron B
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S37-42. PubMed ID: 15536351
[TBL] [Abstract][Full Text] [Related]
9. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
11. [Bronchial cancer--development, diagnosis, therapy, prognosis].
Zöchbauer S; Krajnik G; Huber H
Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
[TBL] [Abstract][Full Text] [Related]
12. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
13. Primary lung cancer invading the chest wall.
McCaughan BC
Chest Surg Clin N Am; 1994 Feb; 4(1):17-28. PubMed ID: 8055279
[TBL] [Abstract][Full Text] [Related]
14. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
Le Cesne A; Arriagada R; Grunenwald D; Baldeyrou P; Girard P; Bretel JJ; Le Chevalier T
Bull Cancer; 1997 Apr; 84(4):413-9. PubMed ID: 9238166
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
Girard N; Mornex F
Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations on the therapy of bronchial carcinoma].
Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
[No Abstract] [Full Text] [Related]
17. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
18. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
Johnson DH; Rusch VW; Turrisi AT
J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
[No Abstract] [Full Text] [Related]
19. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
[TBL] [Abstract][Full Text] [Related]
20. [Curative radiotherapy in locally advanced non-small-cell bronchial carcinoma (NSCLC)].
von Briel C; Betticher DC; Ris HB
Ther Umsch; 1998 Jul; 55(7):402-4. PubMed ID: 9702103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
